Zhao Yingze, Sun Mingwei, Zhang Nan, Liu Xueyuan, Yue Can, Feng Lei, Ji Shushen, Liu Xiao, Qi Jianxun, Wong Catherine C L, Gao George F, Liu William J
NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing 100052, China.
Research Unit of Adaptive Evolution and Control of Emerging Viruses (2018RU009), Chinese Academy of Medical Sciences, Beijing 102206, China.
iScience. 2022 Mar 1;25(4):104013. doi: 10.1016/j.isci.2022.104013. eCollection 2022 Apr 15.
Phosphopeptides presented by major histocompatibility complex (MHC) class I have been regarded as a pivotal type of cancer neoantigens that are recognized by T cells. The structural basis of single-phosphorylated peptide presentation has been well studied. Diphosphorylation with one interval between two sites is one of the prevalent forms of multisite-phosphorylated peptides. Herein, we determined the molecular basis of presentation of two P4/P6 double pS-containing peptides by HLA-B27 and compared them with unmodified and single-phosphorylated peptide complexes. These data clarified not only the HLA allele-specific presentation of phosphopeptides by MHC class I molecules but also the cooperativity of peptide conformation within P4 and P6 phosphorylation sites. The phosphorylation of P6 site can influence the binding mode of P4 phosphorylated site to HLA-B27. And we found the diphospho-dependent attenuated effect of peptide binding affinity. This study provides insights into the MHC presentation features of diphosphopeptides, which is different from monophosphopeptides.
主要组织相容性复合体(MHC)I类分子呈递的磷酸化肽被认为是一类关键的癌症新抗原,可被T细胞识别。单磷酸化肽呈递的结构基础已得到充分研究。两个位点之间间隔一个位点的双磷酸化是多位点磷酸化肽的常见形式之一。在此,我们确定了HLA-B27呈递两种含P4/P6双磷酸化丝氨酸肽的分子基础,并将其与未修饰和单磷酸化肽复合物进行比较。这些数据不仅阐明了MHC I类分子对磷酸化肽的HLA等位基因特异性呈递,还揭示了P4和P6磷酸化位点内肽构象的协同作用。P6位点的磷酸化可影响P4磷酸化位点与HLA-B27的结合模式。并且我们发现了双磷酸化依赖的肽结合亲和力减弱效应。本研究为双磷酸化肽的MHC呈递特征提供了见解,这与单磷酸化肽不同。